Publication | Open Access

Inhibition of ataxia telangiectasia related-3 (ATR) improves therapeutic index in preclinical models of non-small cell lung cancer (NSCLC) radiotherapy

Radiation TherapyPreclinical ModelsMedicineAtaxia Telangiectasia Related-3PathologyCancer TreatmentTherapeutic IndexOncologyRadiation OncologyLung CancerHealth Sciences